How Investors Are Reacting To American Financial Group (AFG) Earnings Jump And Ongoing Share Buybacks

• In the past quarter ended June 30, 2026, American Financial Group, Inc. reported second-quarter revenue of US$2,030 million and net income of US$248 million, with diluted earnings per share from continuing operations of US$2.99, alongside a six‑month revenue of US$3,884 million and net income of US$439 million.
• Over the same period, the company also continued its long-running capital return program, repurchasing 200,231 shares for US$26 million and bringing total buybacks under its 2010 authorization to 46.86 million shares for about US$2.51 billion, underscoring a sustained commitment to reducing share count.
• Next, we’ll examine how this strong year-on-year earnings increase, coupled with ongoing share repurchases, may influence American Financial Group’s investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

American Financial Group Investment Narrative Recap

To own American Financial Group, you need to believe in its ability to generate consistent specialty insurance earnings while managing underwriting, catastrophe and investment risks. The latest quarter’s higher revenue and net income support that earnings-focused case but do not fully resolve concerns around underwriting quality and exposure to alternative investments, which remain key near term catalysts and risks for the stock. Overall, this earnings beat appears supportive rather than transformative for the current narrative.

Among recent announcements, the continued share repurchase activity under the long running 2010 authorization stands out, with US$26 million spent in the June quarter alone. This ongoing reduction in share count can amplify per share earnings outcomes from any improvement in underwriting performance, but it also increases the importance of monitoring underlying loss trends and reserve adequacy as core drivers of long term value.

Yet behind the strong earnings and steady buybacks, investors should be aware of the pressure that sustained catastrophe losses and weaker reserve releases could place on...

Read the full narrative on American Financial Group (it's free!)

American Financial Group's narrative projects $7.6 billion revenue and $1.1 billion earnings by 2029. This implies revenue declining by 1.4% per year and an earnings increase of about $221 million from $879.0 million today.

Uncover how American Financial Group's forecasts yield a $147.17 fair value, in line with its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community currently estimate AFG’s fair value between US$122 and about US$291, reflecting a wide spread of individual views. Against this, recent earnings growth and capital returns highlight how underwriting discipline and investment outcomes could significantly influence how those expectations play out over time, so it is worth comparing several different perspectives before deciding how you see the company.

Explore 3 other fair value estimates on American Financial Group - why the stock might be worth 16% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your American Financial Group research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free American Financial Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate American Financial Group's overall financial health at a glance.

Want Some Alternatives?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com